InsidersTradesSigma
Total declarations
Companies
▲ Purchases (2 ops.)
▼ Sales (0 ops.)
Discover the complete record of transactions filed by ENGELSEN STEINAR J, Director. Officer active across 3 companies, notably INSMED Inc. Aggregated, 4 disclosures have been recorded. Total volume traded: €743k. The latest transaction was disclosed on 1 November 2021 — Acquisition. Regulator: SEC (Form 4). All data is accessible without signup.
Declarations4 total
€371,25114,235 shares@ €26.08010.0010% mcap100.0% of flow
Common Stock
SEC:0001140361-21-036421·
Ideal exit: 29 Jul 2022 (T+270)
€371,25114,235 shares@ €26.08010.0010% mcap100.0% of flow
Common Stock
SEC:0001140361-21-036421:0·
Ideal exit: 29 Jul 2022 (T+270)
7,558 shares
Common Stock
SEC:0001140361-21-017430·
7,558 shares
Common Stock
SEC:0001140361-21-017430:0·
4 of 4 declarations
About ENGELSEN STEINAR J
Steinar J. Engelsen is a Director at INSMED Inc. In this role, he participates in the governance of the company and strategic decision-making. His experience in the pharmaceutical sector is an asset for INSMED, which focuses on developing treatments for rare diseases.
